Enanta Pharmaceuticals, Inc. Announces The Appointment Of George S. Golumbeski, Ph.D. To Board Of Directors

Published: Feb 11, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the appointment of George S. Golumbeski, Ph.D., to its Board of Directors. Dr. Golumbeski will also serve as a member of the Compensation Committee and the Nominating and Corporate Governance Committees.

Help employers find you! Check out all the jobs and post your resume.

Back to news